Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480089 · ClinicalTrials.gov registry record · Phase 4
Surgical Pain Control With Ropivacaine by Atomized Delivery
A Phase 4 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT01480089 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 56 participants.
The verdict
NCT01480089, a Phase 4 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of surgery with minimally invasive (laparoscopic) appendix and gallbladder removal but has not been tried in robotic pelvic surgery.
Interventions
- DRUG Intraperitoneal Ropivacaine (AIR)
- DRUG Atomized Intraperitoneal Saline (AIS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01480089
The ClinicalTrials.gov registry entry for NCT01480089 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intraperitoneal Ropivacaine (AIR) is the first listed.
NCT01480089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01480089 about?
NCT01480089 is a clinical study titled "Surgical Pain Control With Ropivacaine by Atomized Delivery". The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of sur...
What is the current status of trial NCT01480089?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2011-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01480089?
The interventions under investigation include: Intraperitoneal Ropivacaine (AIR) (DRUG), Atomized Intraperitoneal Saline (AIS) (DRUG).
Who is sponsoring clinical trial NCT01480089?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.